During the past decade, BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are "Triple-Negative Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Cancer Cervix" (1 trials), "Cancer Colorectal" (1 trials) and "Cancer Head Neck" (1 trials). Many other conditions were trialed in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" in a lesser frequency.

Most popular intervention types in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Paclitaxel" (2 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials) and "Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]" (1 trials). Other intervention names were less common.

The vast majority of trials in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".